PipelinePharma Logo

Generics

Innovative

Biosimilars 8

Medical devices

Nutraceuticals

Filters

Liraglutide manufacturers

8 products found

Filters

Filters

Filters , active

Country of origin : China

Clear all

8 products found

liraglutide

Injection, pre-filled pen 18 mg/3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #36627

Established in 1993, this manufacturer employs over 1,000 individuals and specializes in fine chemicals, pharmaceutical intermediates, and new materials. As a CTD dossier owner and manufacturer, it holds GMP approvals from multiple countries, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for various chemical and pharmaceutical products, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in numerous countries worldwide.

Manufacturer usually replies in 7 days

liraglutide

Injection, pre-filled pen 18 mg - 3 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Registered in
China
Manufacturer #31065

This biopharmaceutical company specializes in the research, development, production, and marketing of recombinant protein therapeutics and microecological agents. They focus on treating a range of conditions including antiviral, oncology, immunology, hematology, digestive disorders, and degenerative diseases. The company boasts seven world-leading technology platforms, including recombinant protein secretion and expression, long-acting recombinant proteins, and antibody technology. Their product portfolio includes recombinant protein therapeutics such as Human Erythropoietin (EPOSINO), Human Interferon α1b (SINOGEN), and Human Granulocyte Colony-stimulating Factor (WHITE-C), as well as the microecological agent "Combined Clostridium Butyricum and Bifidobacterium (CLOBICO)". The company has a strong presence in major markets such as North America, the EU, Brazil, the Philippines, and Indonesia.

Manufacturer usually replies in 5 days

liraglutide

Injection 18 mg - 3 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #38346
Manufacturer was incorporated on 27 December 2021 in Surat, Gujarat, India, with about 28 employees. As a CTD dossier owner and manufacturer, it operates a WHO-GMP certified and EU-compliant formulation plant under CGMP norms. Products reach markets in India, Yemen, Zambia, Venezuela, Ghana, Kenya, and Tanzania for international presence. Designed to comply with rigorous “Revised Schedule M” rules from India’s Drug Controller. As a CTD dossier owner and manufacturer, it aims for regulatory readiness in global submissions. Recognized as a GMP manufacturer, it ensures standards of safety, purity, and efficacy in all batches.

Manufacturer usually replies in 18 days

Want to see all 8 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Liraglutide Manufacturers

When other medications failed to control blood sugar levels well enough, liraglutide injection (Victoza) is used with a diet and Children and adults aged 10 and up having type 2 diabetes can use an exercise regimen to help control their blood sugar levels. In individuals with type 2 diabetes mellitus with heart and blood vessel disease, liraglutide injection (Victoza) is also used to lower the risk of a heart attack, stroke, or death. Adults with type 1 diabetes or diabetic ketoacidosis are not treated with liraglutide injection (Victoza). Liraglutide injection (Saxenda) is used in combination with a low-calorie diet and exercise regimen to help children and adults 12 years of age and older who weigh 132 pounds (60 kg) or more and are overweight or obese with weight-related health issues lose weight and keep it off. Type 2 diabetes is not treated with liraglutide injection(Saxenda).Best brand of Liraglutideis Saxenda, Victoza and Xultophy. Liraglutide may have some side effects like the problem of urinating or pain or burning on urination, injection site rash or redness, headache, migraine, constipation, indigestion, runny nose, sniffing, or cough weariness.

What's the difference between brand nameLiraglutide vs generic Liraglutide?

Liraglutide Manufacturer's List

Amuna Pharmaceuticals from India Shandong Octagon Chemicals Limited from China Apino Pharma Co., Ltd. from China Xi'an Tian Guangyuan Biotech Co.,Ltd from China Shenzhen JYMed Technology Co.,Ltd. from China Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical Co., Ltd from China SENOVA Technology Co., Ltd. from China Bachem Americas from United States ALP PHARM from China Chengdu Shengnuo from China Hybio Pharmaceutical from China Hainan Shuangcheng from China

Liraglutide on Pipelinepharma

Making use of Pipelinepharma's worldwide B2B online platform for medications and other pharmaceuticals is the best method to identify and gain access theLiraglutidemanufacturers list.Finding reliable producers of specialized pharmaceuticals like sevelamer carbonate could be difficult in the past, but with Pipelinepharma's straightforward search engine and database of proven partners, the process is a lot easier now.To get started, simply use our inbuilt search engine to look for the best brand of Liraglutideor the Best brand of generic Liraglutide with which to collaborate. You may also use other criteria to narrow down your search results, allowing you to look for Liraglutide manufacturers from certain countries.

Price of Liraglutide and how to buy it?

Liraglutide medicine is currently accessible in over 100 countries under the brand name Victoza, including but not limited to Canada, Japan, Brazil, Malaysia, Singapore, India, the United Arab Emirates, Iran, and others. In Australia, Iran, Israel, and North America, the same active ingredient is sold under the brand name Saxenda. Sexanda, unlike Victoza, is available in higher concentrations: it's also available for the Victoza multidose pen in 2.4mg and 3mg active substance solutions. It's also sold under the brand name Xultophy in some countries as a combination solution with the component insulin degludec, at a concentration of 100IU + 3.6mg. Novo Nordisk A/S, a Danish corporation, developed and distributes liraglutide internationally, and was granted a patent on the medicine that is valid until 2022. The price of Liraglutide 8mg per 1 ml of size 5 costs $272.22.

FAQ About Liraglutide

1.Who manufacturers Liraglutide?

Saxenda, Victoza, and Xultophy are manufacturing brands of Liraglutide

2.Which brand of Liraglutide is best?

Victoza is known to be the best brand of Liraglutide

3.Is Liraglutide manufactured in the USA?

Liraglutide is an approved drug with prescription in the USA. But there is no precise information regarding the manufacturing in the USA of the same.

4.Are all brands of Liraglutide the same?

No, not all brands are the same. Different brands have different ingredients added as well as they have different or additional functions added to them.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.